259 related articles for article (PubMed ID: 22353833)
61. Breast cancer screening: have there been any changes during the last decade? A study in a Spanish unit.
Martínez-Ramos D; Escrig-Sos J; García-Redón T; Fortea-Sanchis C; Alcalde-Sánchez M; Salvador-Sanchis JL
Cir Cir; 2011; 79(5):402-8. PubMed ID: 22385759
[TBL] [Abstract][Full Text] [Related]
62. Ductal carcinoma in situ.
Loring L; Dershaw DD
Crit Rev Diagn Imaging; 1997 Dec; 38(6):501-33. PubMed ID: 9442977
[TBL] [Abstract][Full Text] [Related]
63. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
64. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
65. [Breast cancer screening in the elderly].
Amodeo C; Caglià P; Gandolfo L; Veroux M; Brancato G; Immè A
Tumori; 2003; 89(4 Suppl):173-4. PubMed ID: 12903582
[TBL] [Abstract][Full Text] [Related]
66. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Anderson BO
J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
[No Abstract] [Full Text] [Related]
67. [Comparative analysis of early diagnostic tools for breast cancer].
Shen SJ; Sun Q; Xu YL; Zhou YD; Guan JH; Mao F; Lin Y; Wang XJ; Han SM
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):877-80. PubMed ID: 23291142
[TBL] [Abstract][Full Text] [Related]
68. [Mammography breast cancer screening in Italy: 2010 survey].
Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):8-27. PubMed ID: 23293268
[TBL] [Abstract][Full Text] [Related]
69. Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening.
Verdial FC; Etzioni R; Duggan C; Anderson BO
J Surg Oncol; 2017 Apr; 115(5):517-522. PubMed ID: 28194807
[TBL] [Abstract][Full Text] [Related]
70. Breast Cancer Detection Rate, Incidence, Prevalence and Interval Cancer-related Mammography Screening Times among Thai Women.
Sripaiboonkij N; Thinkamrop B; Promthet S; Kannawat C; Tangcharoensathien V; Ansusing T; Rattanamongkolgul S
Asian Pac J Cancer Prev; 2016; 17(8):4137-41. PubMed ID: 27644674
[TBL] [Abstract][Full Text] [Related]
71. US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey.
Schwartz LM; Woloshin S; Sox HC; Fischhoff B; Welch HG
West J Med; 2000 Nov; 173(5):307-12. PubMed ID: 11069862
[TBL] [Abstract][Full Text] [Related]
72. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
73. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
Michalopoulos D; Duffy SW
J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
[TBL] [Abstract][Full Text] [Related]
74. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
Yen MF; Tabár L; Vitak B; Smith RA; Chen HH; Duffy SW
Eur J Cancer; 2003 Aug; 39(12):1746-54. PubMed ID: 12888370
[TBL] [Abstract][Full Text] [Related]
75. [Breast cancer in Mexican women under 40].
Robles-Castillo J; Ruvalcaba-Limón E; Maffuz A; Rodríguez-Cuevas S
Ginecol Obstet Mex; 2011 Aug; 79(8):482-8. PubMed ID: 21966845
[TBL] [Abstract][Full Text] [Related]
76. Absence of sustained breast cancer incidence inflation in a national mammography screening programme.
Morrell S; Gregory M; Sexton K; Wharton J; Sharma N; Taylor R
J Med Screen; 2019 Mar; 26(1):26-34. PubMed ID: 29950138
[TBL] [Abstract][Full Text] [Related]
77. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
Foca F; Mancini S; Bucchi L; Puliti D; Zappa M; Naldoni C; Falcini F; Gambino ML; Piffer S; Sanoja Gonzalez ME; Stracci F; Zorzi M; Paci E;
Cancer; 2013 Jun; 119(11):2022-8. PubMed ID: 23504860
[TBL] [Abstract][Full Text] [Related]
78. Mammography for symptomless women--not so wise?
Cutler WB; Burki RE; Kolter J; Chambliss C
Climacteric; 2013 Jun; 16(3):313-5. PubMed ID: 23425505
[TBL] [Abstract][Full Text] [Related]
79. Differences in screening mammography outcomes among White, Chinese, and Filipino women.
Kerlikowske K; Creasman J; Leung JW; Smith-Bindman R; Ernster VL
Arch Intern Med; 2005 Sep; 165(16):1862-8. PubMed ID: 16157830
[TBL] [Abstract][Full Text] [Related]
80. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
Zakaria D; Shaw A
Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
